In this installment of the Innovations in Facial Plastic Surgery Update, Dr. Verret discusses the latest information from the US FDA regarding Botox(r) as well as Dysport(tm), the most recently approved botulinum toxin formulation in the United States. To read the FDA's recent information regarding Botox(r), visit http://www.fda.gov/bbs/topics/NEWS/2009/NEW02005.html. For more information about Dysport(tm) visit http://www.medicis.com. To learn when Dysport(tm) will be available in Dallas, Texas, visit Dr. Verret at http://www.innovationsfps.com. keywords: Botox, Dysport, Glabellar Furrows, botulinum toxin, Dallas, Texas, Plano.
